Specializes company in the research and development of solutions and treatments using phage therapy for multi-resistant infections
Vésale Bioscience has raised €1.8M across 1 funding round from 1 investor, most recently a Grant round in Jan 2023. Based in Namur, Belgium; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-18 | Grant | €1.8M |
| European Innovation Council (EIC) |
| View deal → |
